Overview
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
Status:
Terminated
Terminated
Trial end date:
2007-08-01
2007-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bausch & Lomb IncorporatedTreatments:
Fibrinolysin
Criteria
Inclusion Criteria:- Patients who would benefit from a posterior vitreous detachment, as determined by the
evaluating ophthalmologist.
Exclusion Criteria:
- Presence of a posterior vitreous detachment in the study eye
- History of vitrectomy in the study eye
- Proliferative diabetic retinopathy in the study eye
- Presence of media opacity that precludes quality examination of the vitreous and
fundus.